EPIDEMIOLOGIC SURVEILLANCE OF CREUTZFELDT-JAKOB DISEASE IN THE UNITED-KINGDOM

被引：15

作者：

WILL, RG

机构：

[1] Department of Clinical Neuroscience, Western General Hospital, Edinburgh

来源：

EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1991年 / 7卷 / 05期

关键词：

CREUTZFELDT-JAKOB DISEASE; EPIDEMIOLOGY; UNITED-KINGDOM;

D O I：

10.1007/BF00143122

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Systematic epidemiological surveillance of Creutzfeldt-Jakob disease was carried out in England and Wales covering the years 1970-1984. The results of this work provide a basis from which to assess any change in the pattern of Creutzfeldt-Jakob disease following the occurrence of Bovine Spongiform Encephalopathy. The methodology, early results and problems of the current systematic national survey of CJD, initiated in May 1990, are discussed.

引用

页码：460 / 465

页数：6

共 22 条

[1]

Alter M., Creutzfeldt-Jakob disease: hypothesis for high incidence in Libyan Jews in Israel, Science, 186, (1974)

[2]

Alter M., Frank Y., Doyne H., Creutzfeldt-Jakob disease after eating ovine brains?, New Engl. J. Med., 292, (1975)

[3]

Billette de Villemeur T., Beauvais P., Gourmelen M., Richardet J.M., Creutzfeldt-Jakob disease in children treated with growth hormone (Letter), Lancet, 337, pp. 864-865, (1991)

[4]

Bobowick A.R., Brody J.A., Matthews M.R., Roos R., Gajdusek D.C., Creutzfeldt-Jakob disease: A case-control study, Am. J. Epidemiol., 98, pp. 381-394, (1973)

[5]

Brown P., Cathala F., Gajdusek D.C., Creutzfeldt-Jakob disease in France: III. Epidemiological study of 170 patients dying during the decade 1968–1977, Ann. Neurol., 6, pp. 438-446, (1979)

[6]

Brown P., Cathala F., Raubertas R.F., Cajdusek D.C., Cataigne P., The epidemiology of Creutzfeldt-Jakob disease: Conclusion of a 15-year investigation in France and review of the world literature, Neurology, 37, pp. 895-904, (1987)

[7]

Brown P., Rodgers-Johnson P., Cathala F., Gibbs C.J., Gajdusek D.C, Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis, Ann. Neurol., 16, pp. 295-304, (1984)

[8]

Buchanan C.R., Preece M.A., Milner R.D.G., Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom, BMJ, 302, pp. 824-828, (1991)

[9]

Cousens S.N., Harries-Jones R., Knight R., Will R.G., Smith P.G., Matthews W.B., Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970–84, J. Neurol. Neurosurg. Psych., 53, pp. 459-465, (1990)

[10]

Davanipour Z., Alter M., Sobel E., Asher D.M., Gajdusek D.C., A case-control study of Creutzfeldt-Jakob disease: dietary risk factors, Am. J. Epidemiol., 122, pp. 443-451, (1985)

← 1 2 3 →